3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Breast Neoplasms
10
Colorectal Neoplasms
8
Lung Neoplasms
6
Carcinoma, Non-Small-Cell Lung
6
Pancreatic Neoplasms
5
Neoplastic Cells, Circulating
4
Neoplasm Metastasis
4
Biliary Tract Neoplasms
4
Recurrence
3
Prostatic Neoplasms
3
Oropharyngeal Neoplasms
3
Neoplasm, Residual
3
Disease
3
Squamous Cell Carcinoma of Head and Neck
2
Nevi and Melanomas
2
Neuroendocrine Tumors
2
Nasopharyngeal Carcinoma
2
NSCLC
2
Melanoma
2
Head and Neck Neoplasms
2
Cholangiocarcinoma
2
Carcinoma, Hepatocellular
2
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Uterine Cervical Dysplasia
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Smoking
1
Sarcoma, Ewing
1
Interventions
AZD 6244
4
trametinib
2
cabozantinib
2
Imatinib Mesylate
2
pirfenidone
1
peginterferon alfa-2b
1
nilotinib
1
binimetinib
1
Vinblastine
1
Methotrexate
1
Liquid Biopsy
1
Gadolinium DTPA
1
Fluorodeoxyglucose F18
1
Cryotherapy
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurofibroma, Plexiform
×
Liquid Biopsy
×
Clear all
NCT06515860
2026-01-09
NF1-TED
Boston Children's Hospital
Recruiting
1,000 enrolled